Abstract:Background: The combination of anatomical MRI and deep learning-based methods such as convolutional neural networks (CNNs) is a promising strategy to build predictive models of multiple sclerosis (MS) prognosis. However, studies assessing the effect of different input strategies on model's performance are lacking. Purpose: To compare whole-brain input sampling strategies and regional/specific-tissue strategies, which focus on a priori known relevant areas for disability accrual, to stratify MS patients based on their disability level. Study type: Retrospective. Subjects: Three hundred nineteen MS patients (382 brain MRI scans) with clinical assessment of disability level performed within the following 6 months (~70% training/~15% validation/~15% inference in-house dataset) and 440 MS patients from multiple centers (independent external validation cohort). Field strength/sequence: Single vendor 1.5 T or 3.0 T. Magnetization-Prepared Rapid Gradient-Echo and Fluid-Attenuated Inversion Recovery sequences. Assessment: A 7-fold patient cross validation strategy was used to train a 3D-CNN to classify patients into two groups, Expanded Disability Status Scale score (EDSS) ≥ 3.0 or EDSS < 3.0. Two strategies were investigated: 1) a global approach, taking the whole brain volume as input and 2) regional approaches using five different regions-of-interest: white matter, gray matter, subcortical gray matter, ventricles, and brainstem structures. The performance of the models was assessed in the in-house and the independent external cohorts. Statistical tests: Balanced accuracy, sensitivity, specificity, area under receiver operating characteristic (ROC) curve (AUC). Results: With the in-house dataset, the gray matter regional model showed the highest stratification accuracy (81%), followed by the global approach (79%). In the external dataset, without any further retraining, an accuracy of 72% was achieved for the white matter model and 71% for the global approach. Data conclusion: The global approach offered the best trade-off between internal performance and external validation to stratify MS patients based on accumulated disability. Evidence level: 4 TECHNICAL EFFICACY: Stage 2.

Personalized Prediction of Future Lesion Activity and Treatment Effect in Multiple Sclerosis from Baseline MRI

Probabilistic Temporal Prediction of Continuous Disease Trajectories and Treatment Effects Using Neural SDEs

Predicting multiple sclerosis disease severity with multimodal deep neural networks

Machine Learning Algorithms for Early Prediction of Multiple Sclerosis Progression: A Comparative Study

Prediction of Expanded Disability Status Scale in patients with MS using deep learning

An Algorithm to Predict the Need for Magnetic Resonance Imaging to Support Disease Monitoring in Multiple Sclerosis

Predicting multiple sclerosis disease progression and outcomes with machine learning and MRI-based biomarkers: a review

Global and Regional Deep Learning Models for Multiple Sclerosis Stratification From MRI

Benchmarking Continuous Time Models for Predicting Multiple Sclerosis Progression

Temporally Adjustable Longitudinal Fluid-Attenuated Inversion Recovery MRI Estimation / Synthesis for Multiple Sclerosis

A future of AI-driven personalized care for people with multiple sclerosis

Prediction of unenhanced lesion evolution in multiple sclerosis using radiomics-based models: a machine learning approach

Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis

Predicting disease severity in multiple sclerosis using multimodal data and machine learning

Collaboration between a human group and artificial intelligence can improve prediction of multiple sclerosis course: a proof-of-principle study

Self-pruning Graph Neural Network for Predicting Inflammatory Disease Activity in Multiple Sclerosis from Brain MR Images

Deciphering multiple sclerosis disability with deep learning attention maps on clinical MRI

Interpretable deep learning as a means for decrypting disease signature in multiple sclerosis

Cortical lesions, central vein sign, and paramagnetic rim lesions in multiple sclerosis: emerging machine learning techniques and future avenues

Deep learning prediction of pathological complete response, residual cancer burden, and progression-free survival in breast cancer patients

Disability prediction in multiple sclerosis using performance outcome measures and demographic data